APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonclinical Safety Assessment Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nonclinical Safety Assessment Service Market Analysis and Forecast 2026-2032

15 April 2026245 pages

Choose your research edition.

Industry ResearchNonclinical Safety Assessment Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonclinical Safety Assessment Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nonclinical Safety Assessment Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonclinical Safety Assessment Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Nonclinical Safety Assessment Service Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global Nonclinical Safety Assessment Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nonclinical Safety Assessment Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nonclinical Safety Assessment Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nonclinical Safety Assessment Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nonclinical Safety Assessment Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nonclinical Safety Assessment Service include WuXi AppTec, Joinn Laboratories, Innoscience, Westchina-Frontier Pharma Tech, Pharmaron, Gradient, Biopharma Excellence, Evotec and Charles River, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nonclinical Safety Assessment Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nonclinical Safety Assessment Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Nonclinical Safety Assessment Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nonclinical Safety Assessment Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nonclinical Safety Assessment Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nonclinical Safety Assessment Service revenue, projected growth trends, production technology, application and end-user industry.

Nonclinical Safety Assessment Service Segment by Company

WuXi AppTec

Joinn Laboratories

Innoscience

Westchina-Frontier Pharma Tech

Pharmaron

Gradient

Biopharma Excellence

Evotec

Charles River

labcorp

CellPurics

Medicilon

Nonclinical Safety Assessment Service Segment by Type

Safety Assessment for Drug

Safety Assessment for Medical Devices

Nonclinical Safety Assessment Service Segment by Application

Pharmaceutical Companies

Biotechnology Companies

CRO

Others

Nonclinical Safety Assessment Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonclinical Safety Assessment Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonclinical Safety Assessment Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonclinical Safety Assessment Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nonclinical Safety Assessment Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nonclinical Safety Assessment Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nonclinical Safety Assessment Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nonclinical Safety Assessment Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Safety Assessment for Drug Major Player Table 3. Safety Assessment for Medical Devices Major Player Table 4. Global Nonclinical Safety Assessment Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Companies Major Player Table 6. Biotechnology Companies Major Player Table 7. CRO Major Player Table 8. Others Major Player Table 9. Nonclinical Safety Assessment Service Industry Trends Table 10. Nonclinical Safety Assessment Service Industry Drivers Table 11. Nonclinical Safety Assessment Service Industry Opportunities and Challenges Table 12. Nonclinical Safety Assessment Service Industry Restraints Table 13. Global Nonclinical Safety Assessment Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nonclinical Safety Assessment Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nonclinical Safety Assessment Service Market Share by Region (2021-2026) Table 16. Global Nonclinical Safety Assessment Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nonclinical Safety Assessment Service Market Share by Region (2027-2032) Table 18. Global Nonclinical Safety Assessment Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Nonclinical Safety Assessment Service Revenue Market Share by Players (2021-2026) Table 20. Global Nonclinical Safety Assessment Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nonclinical Safety Assessment Service Key Players Headquarters & Area Served Table 22. Global Nonclinical Safety Assessment Service Players, Product Type & Application Table 23. Global Nonclinical Safety Assessment Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Nonclinical Safety Assessment Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Nonclinical Safety Assessment Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Nonclinical Safety Assessment Service Revenue Market Share by Type (2021-2026) Table 30. Global Nonclinical Safety Assessment Service Revenue Market Share by Type (2027-2032) Table 31. Global Nonclinical Safety Assessment Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Nonclinical Safety Assessment Service Revenue Market Share by Application (2021-2026) Table 35. Global Nonclinical Safety Assessment Service Revenue Market Share by Application (2027-2032) Table 36. WuXi AppTec Company Information Table 37. WuXi AppTec Business Overview Table 38. WuXi AppTec Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. WuXi AppTec Nonclinical Safety Assessment Service Product Portfolio Table 40. WuXi AppTec Recent Development Table 41. Joinn Laboratories Company Information Table 42. Joinn Laboratories Business Overview Table 43. Joinn Laboratories Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Joinn Laboratories Nonclinical Safety Assessment Service Product Portfolio Table 45. Joinn Laboratories Recent Development Table 46. Innoscience Company Information Table 47. Innoscience Business Overview Table 48. Innoscience Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Innoscience Nonclinical Safety Assessment Service Product Portfolio Table 50. Innoscience Recent Development Table 51. Westchina-Frontier Pharma Tech Company Information Table 52. Westchina-Frontier Pharma Tech Business Overview Table 53. Westchina-Frontier Pharma Tech Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Westchina-Frontier Pharma Tech Nonclinical Safety Assessment Service Product Portfolio Table 55. Westchina-Frontier Pharma Tech Recent Development Table 56. Pharmaron Company Information Table 57. Pharmaron Business Overview Table 58. Pharmaron Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pharmaron Nonclinical Safety Assessment Service Product Portfolio Table 60. Pharmaron Recent Development Table 61. Gradient Company Information Table 62. Gradient Business Overview Table 63. Gradient Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Gradient Nonclinical Safety Assessment Service Product Portfolio Table 65. Gradient Recent Development Table 66. Biopharma Excellence Company Information Table 67. Biopharma Excellence Business Overview Table 68. Biopharma Excellence Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Biopharma Excellence Nonclinical Safety Assessment Service Product Portfolio Table 70. Biopharma Excellence Recent Development Table 71. Evotec Company Information Table 72. Evotec Business Overview Table 73. Evotec Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Evotec Nonclinical Safety Assessment Service Product Portfolio Table 75. Evotec Recent Development Table 76. Charles River Company Information Table 77. Charles River Business Overview Table 78. Charles River Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Charles River Nonclinical Safety Assessment Service Product Portfolio Table 80. Charles River Recent Development Table 81. labcorp Company Information Table 82. labcorp Business Overview Table 83. labcorp Nonclinical Safety Assessment Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. labcorp Nonclinical Safety Assessment Service Product Portfolio Table 85. labcorp Recent Development Table 86. CellPurics Company Information Table 87. CellPurics Business Overview Table 88. CellPurics Nonclinical Safety Assessment Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. CellPurics Nonclinical Safety Assessment Service Product Portfolio Table 90. CellPurics Recent Development Table 91. Medicilon Company Information Table 92. Medicilon Business Overview Table 93. Medicilon Nonclinical Safety Assessment Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Medicilon Nonclinical Safety Assessment Service Product Portfolio Table 95. Medicilon Recent Development Table 96. North America Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Nonclinical Safety Assessment Service Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Nonclinical Safety Assessment Service Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Nonclinical Safety Assessment Service Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Nonclinical Safety Assessment Service Revenue by Country (US$ Million) & (2027-2032) Table 110. China Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 111. China Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 112. China Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 113. China Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Nonclinical Safety Assessment Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Nonclinical Safety Assessment Service Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Nonclinical Safety Assessment Service Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Nonclinical Safety Assessment Service Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Nonclinical Safety Assessment Service Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Nonclinical Safety Assessment Service Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Nonclinical Safety Assessment Service Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Nonclinical Safety Assessment Service Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Nonclinical Safety Assessment Service Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Nonclinical Safety Assessment Service Image Figure 2. Global Nonclinical Safety Assessment Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nonclinical Safety Assessment Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Safety Assessment for Drug Image Figure 5. Safety Assessment for Medical Devices Image Figure 6. Global Nonclinical Safety Assessment Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nonclinical Safety Assessment Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Companies Image Figure 9. Biotechnology Companies Image Figure 10. CRO Image Figure 11. Others Image Figure 12. Global Nonclinical Safety Assessment Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Nonclinical Safety Assessment Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nonclinical Safety Assessment Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Nonclinical Safety Assessment Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Nonclinical Safety Assessment Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nonclinical Safety Assessment Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nonclinical Safety Assessment Service Revenue Market Share by Type (2021-2032) Figure 20. Global Nonclinical Safety Assessment Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nonclinical Safety Assessment Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Nonclinical Safety Assessment Service Revenue Market Share by Application (2021-2032) Figure 23. North America Nonclinical Safety Assessment Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032) Figure 25. North America Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032) Figure 26. North America Nonclinical Safety Assessment Service Revenue Share by Country (2021-2032) Figure 27. United States Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Nonclinical Safety Assessment Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032) Figure 32. Europe Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032) Figure 33. Europe Nonclinical Safety Assessment Service Revenue Share by Country (2021-2032) Figure 34. Germany Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Nonclinical Safety Assessment Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032) Figure 44. China Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032) Figure 45. Asia Nonclinical Safety Assessment Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032) Figure 47. Asia Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032) Figure 48. Asia Nonclinical Safety Assessment Service Revenue Share by Region (2021-2032) Figure 49. Japan Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Nonclinical Safety Assessment Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Nonclinical Safety Assessment Service Revenue Share by Country (2021-2032) Figure 59. Brazil Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Nonclinical Safety Assessment Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Assessment for Drug
  • Safety Assessment for Medical Devices
Applications
  • Pharmaceutical Companies
  • Biotechnology Companies
  • CRO
  • Others
Companies covered
  • WuXi AppTec
  • Joinn Laboratories
  • Innoscience
  • Westchina-Frontier Pharma Tech
  • Pharmaron
  • Gradient
  • Biopharma Excellence
  • Evotec
  • Charles River
  • labcorp
  • CellPurics
  • Medicilon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nonclinical Safety Assessment Service Market by Type
  3. 1.2.1 Global Nonclinical Safety Assessment Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Safety Assessment for Drug
  5. 1.2.3 Safety Assessment for Medical Devices
  6. 1.3 Nonclinical Safety Assessment Service Market by Application
  7. 1.3.1 Global Nonclinical Safety Assessment Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Companies
  9. 1.3.3 Biotechnology Companies
  10. 1.3.4 CRO
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nonclinical Safety Assessment Service Market Dynamics
  1. 2.1 Nonclinical Safety Assessment Service Industry Trends
  2. 2.2 Nonclinical Safety Assessment Service Industry Drivers
  3. 2.3 Nonclinical Safety Assessment Service Industry Opportunities and Challenges
  4. 2.4 Nonclinical Safety Assessment Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nonclinical Safety Assessment Service Market Perspective (2021-2032)
  2. 3.2 Global Nonclinical Safety Assessment Service Growth Trends by Region
  3. 3.2.1 Global Nonclinical Safety Assessment Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nonclinical Safety Assessment Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Nonclinical Safety Assessment Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nonclinical Safety Assessment Service Revenue by Players
  2. 4.1.1 Global Nonclinical Safety Assessment Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Nonclinical Safety Assessment Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nonclinical Safety Assessment Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nonclinical Safety Assessment Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nonclinical Safety Assessment Service Key Players Headquarters & Area Served
  7. 4.4 Global Nonclinical Safety Assessment Service Players, Product Type & Application
  8. 4.5 Global Nonclinical Safety Assessment Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nonclinical Safety Assessment Service Market CR5 and HHI
  11. 4.6.3 2025 Nonclinical Safety Assessment Service Tier 1, Tier 2, and Tier 3
5 Nonclinical Safety Assessment Service Market Size by Type
  1. 5.1 Global Nonclinical Safety Assessment Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 5.3 Global Nonclinical Safety Assessment Service Revenue Market Share by Type (2021-2032)
6 Nonclinical Safety Assessment Service Market Size by Application
  1. 6.1 Global Nonclinical Safety Assessment Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  3. 6.3 Global Nonclinical Safety Assessment Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WuXi AppTec
  2. 7.1.1 WuXi AppTec Company Information
  3. 7.1.2 WuXi AppTec Business Overview
  4. 7.1.3 WuXi AppTec Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WuXi AppTec Nonclinical Safety Assessment Service Product Portfolio
  6. 7.1.5 WuXi AppTec Recent Developments
  7. 7.2 Joinn Laboratories
  8. 7.2.1 Joinn Laboratories Company Information
  9. 7.2.2 Joinn Laboratories Business Overview
  10. 7.2.3 Joinn Laboratories Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Joinn Laboratories Nonclinical Safety Assessment Service Product Portfolio
  12. 7.2.5 Joinn Laboratories Recent Developments
  13. 7.3 Innoscience
  14. 7.3.1 Innoscience Company Information
  15. 7.3.2 Innoscience Business Overview
  16. 7.3.3 Innoscience Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Innoscience Nonclinical Safety Assessment Service Product Portfolio
  18. 7.3.5 Innoscience Recent Developments
  19. 7.4 Westchina-Frontier Pharma Tech
  20. 7.4.1 Westchina-Frontier Pharma Tech Company Information
  21. 7.4.2 Westchina-Frontier Pharma Tech Business Overview
  22. 7.4.3 Westchina-Frontier Pharma Tech Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Westchina-Frontier Pharma Tech Nonclinical Safety Assessment Service Product Portfolio
  24. 7.4.5 Westchina-Frontier Pharma Tech Recent Developments
  25. 7.5 Pharmaron
  26. 7.5.1 Pharmaron Company Information
  27. 7.5.2 Pharmaron Business Overview
  28. 7.5.3 Pharmaron Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pharmaron Nonclinical Safety Assessment Service Product Portfolio
  30. 7.5.5 Pharmaron Recent Developments
  31. 7.6 Gradient
  32. 7.6.1 Gradient Company Information
  33. 7.6.2 Gradient Business Overview
  34. 7.6.3 Gradient Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Gradient Nonclinical Safety Assessment Service Product Portfolio
  36. 7.6.5 Gradient Recent Developments
  37. 7.7 Biopharma Excellence
  38. 7.7.1 Biopharma Excellence Company Information
  39. 7.7.2 Biopharma Excellence Business Overview
  40. 7.7.3 Biopharma Excellence Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biopharma Excellence Nonclinical Safety Assessment Service Product Portfolio
  42. 7.7.5 Biopharma Excellence Recent Developments
  43. 7.8 Evotec
  44. 7.8.1 Evotec Company Information
  45. 7.8.2 Evotec Business Overview
  46. 7.8.3 Evotec Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Evotec Nonclinical Safety Assessment Service Product Portfolio
  48. 7.8.5 Evotec Recent Developments
  49. 7.9 Charles River
  50. 7.9.1 Charles River Company Information
  51. 7.9.2 Charles River Business Overview
  52. 7.9.3 Charles River Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Charles River Nonclinical Safety Assessment Service Product Portfolio
  54. 7.9.5 Charles River Recent Developments
  55. 7.10 labcorp
  56. 7.10.1 labcorp Company Information
  57. 7.10.2 labcorp Business Overview
  58. 7.10.3 labcorp Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 labcorp Nonclinical Safety Assessment Service Product Portfolio
  60. 7.10.5 labcorp Recent Developments
  61. 7.11 CellPurics
  62. 7.11.1 CellPurics Company Information
  63. 7.11.2 CellPurics Business Overview
  64. 7.11.3 CellPurics Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CellPurics Nonclinical Safety Assessment Service Product Portfolio
  66. 7.11.5 CellPurics Recent Developments
  67. 7.12 Medicilon
  68. 7.12.1 Medicilon Company Information
  69. 7.12.2 Medicilon Business Overview
  70. 7.12.3 Medicilon Nonclinical Safety Assessment Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medicilon Nonclinical Safety Assessment Service Product Portfolio
  72. 7.12.5 Medicilon Recent Developments
8 North America
  1. 8.1 North America Nonclinical Safety Assessment Service Revenue (2021-2032)
  2. 8.2 North America Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Nonclinical Safety Assessment Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Nonclinical Safety Assessment Service Revenue by Type (2027-2032)
  5. 8.3 North America Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Nonclinical Safety Assessment Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Nonclinical Safety Assessment Service Revenue by Application (2027-2032)
  9. 8.5 North America Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Nonclinical Safety Assessment Service Revenue by Country
  11. 8.6.1 North America Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nonclinical Safety Assessment Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Nonclinical Safety Assessment Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nonclinical Safety Assessment Service Revenue (2021-2032)
  2. 9.2 Europe Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nonclinical Safety Assessment Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nonclinical Safety Assessment Service Revenue by Type (2027-2032)
  5. 9.3 Europe Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nonclinical Safety Assessment Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nonclinical Safety Assessment Service Revenue by Application (2027-2032)
  9. 9.5 Europe Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nonclinical Safety Assessment Service Revenue by Country
  11. 9.6.1 Europe Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nonclinical Safety Assessment Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nonclinical Safety Assessment Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nonclinical Safety Assessment Service Revenue (2021-2032)
  2. 10.2 China Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 10.2.1 China Nonclinical Safety Assessment Service Revenue by Type (2021-2026)
  4. 10.2.2 China Nonclinical Safety Assessment Service Revenue by Type (2027-2032)
  5. 10.3 China Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032)
  6. 10.4 China Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  7. 10.4.1 China Nonclinical Safety Assessment Service Revenue by Application (2021-2026)
  8. 10.4.2 China Nonclinical Safety Assessment Service Revenue by Application (2027-2032)
  9. 10.5 China Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nonclinical Safety Assessment Service Revenue (2021-2032)
  2. 11.2 Asia Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nonclinical Safety Assessment Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nonclinical Safety Assessment Service Revenue by Type (2027-2032)
  5. 11.3 Asia Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nonclinical Safety Assessment Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nonclinical Safety Assessment Service Revenue by Application (2027-2032)
  9. 11.5 Asia Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nonclinical Safety Assessment Service Revenue by Country
  11. 11.6.1 Asia Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nonclinical Safety Assessment Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nonclinical Safety Assessment Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nonclinical Safety Assessment Service Revenue (2021-2032)
  2. 12.2 SAMEA Nonclinical Safety Assessment Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nonclinical Safety Assessment Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nonclinical Safety Assessment Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nonclinical Safety Assessment Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nonclinical Safety Assessment Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nonclinical Safety Assessment Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nonclinical Safety Assessment Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nonclinical Safety Assessment Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nonclinical Safety Assessment Service Revenue by Country
  11. 12.6.1 SAMEA Nonclinical Safety Assessment Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nonclinical Safety Assessment Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nonclinical Safety Assessment Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst